Toolbox · Review

Reframe: In-Depth Review

This article may contain affiliate links. If you purchase through them, we may earn a small commission at no extra cost to you. See our Affiliate Disclosure for details.

Reframe is a consumer app for people who want to reduce or stop drinking. It has gained significant traction in the drinking-reduction space over the past several years, and its marketing emphasizes a "neuroscience-based" approach. This review evaluates what Reframe actually is, what the evidence supports, and who it is and is not a reasonable fit for.

This review discusses Reframe because users frequently ask about it. AvoidRehab may or may not have an affiliate relationship with Reframe at the time of your reading; see Affiliate Disclosure. Our review is independent either way.

What Reframe is

Reframe is a smartphone app designed for people who want to reduce their drinking or quit. The core product is a 160-day structured program of daily content, delivered primarily through the app, combined with:

  • Progress tracking (drinks, days, goals).
  • Toolkits for craving management, social drinking situations, and common triggers.
  • A community feature where users share progress and support each other.
  • Optional one-on-one coaching (additional cost).
  • In-app content on sleep, nutrition, and related variables.

The daily content is framed around a "neuroscience of habit change" narrative, content that describes the brain mechanisms underlying alcohol use and habit formation, paired with cognitive-behavioral skills and psychoeducational material.

The approach

The active ingredients in Reframe, translated into clinical language, are a combination of:

  • Psychoeducation about alcohol and the brain.
  • Self-monitoring (tracking drinks, urges, patterns).
  • Cognitive-behavioral skills (identifying triggers, managing urges, cognitive restructuring).
  • Behavioral activation (healthier routines, sleep, exercise).
  • Peer community (mutual support, normalization).
  • Goal-setting oriented toward moderation or abstinence, depending on the user's choice.

These are legitimate components of evidence-based care for non-severe alcohol use. The question is whether they are delivered adequately through an app and for whom.

What the evidence shows

Reframe has published data from user cohorts showing reductions in drinking among engaged users over the course of the program. These results are consistent with what structured drinking-reduction interventions produce more broadly. A few honest observations about the evidence base:

  • No large randomized controlled trial of Reframe specifically against a comparator has been published at the time of this review.
  • Self-selected user cohorts are a weaker evidence source than RCTs, users who download and engage with a drinking-reduction app are, as a group, more motivated than a population average, and their outcomes reflect that.
  • The underlying approach (psychoeducation + CBT skills + self-monitoring + peer support) has moderate evidence when delivered in general, including in app format. That does not prove Reframe specifically is effective, but it means the design is aligned with approaches that work.
  • Engagement is a limiting factor, as with most consumer apps, a substantial portion of users do not complete the program. Users who do engage tend to see benefit.

A calibrated summary: Reframe is consistent with evidence-based approaches, has promising uncontrolled user data, and has not yet been validated by the gold-standard research that would establish specific efficacy claims.

Who Reframe fits

Reframe is a reasonable fit for:

  • Heavy social drinkers or early-stage problem drinkers who are motivated to reduce or stop.
  • People who prefer self-directed digital tools over therapy or mutual-help groups.
  • People pursuing moderation rather than strict abstinence (Reframe supports both).
  • People who are privacy-sensitive and not ready to enter formal treatment or mutual-help settings.
  • Adjunctive users, people already in outpatient care who want additional daily structure.

Who Reframe does not fit

Reframe is not a fit for:

  • Moderate-to-severe alcohol use disorder. Patients who meet DSM criteria for moderate or severe AUD need clinician-directed care, typically including MAUD, outpatient therapy, and sometimes structured programming. An app is not adequate. See Medications for Alcohol Use Disorder.
  • Physical alcohol dependence. Patients who experience withdrawal symptoms (tremor, sweating, anxiety) when they stop drinking need clinician-supervised withdrawal management. Reducing drinking without clinical oversight carries medical risk, including (rarely but seriously) withdrawal seizures. This is not a population an app can safely serve alone.
  • Co-occurring mental health conditions. Depression, anxiety, PTSD, and other conditions that drive drinking require integrated clinical treatment.
  • Patients with a history of failed self-directed attempts. If someone has tried to reduce drinking multiple times on their own and not succeeded, an app without clinical support is unlikely to produce a different result.
  • Patients in crisis. Active suicidality, acute withdrawal, or medical complications require immediate clinical care, not app access.

How Reframe compares to alternatives

Versus outpatient therapy. For mild alcohol issues, Reframe is substantially cheaper and more accessible than therapy. For moderate-to-severe AUD, therapy (combined with medication) is more effective and medically safer.

Versus mutual-help groups. AA, SMART Recovery, Moderation Management, and similar are free. Reframe is paid. The daily structure and psychoeducation Reframe offers are not standard features of most mutual-help meetings, so there is a real product difference.

Versus other drinking reduction apps (Sunnyside, Cutback Coach, etc.). The drinking-reduction app space is crowded. Reframe is one of the better-developed options in terms of content depth and program structure; other apps are simpler and less expensive. User fit varies.

Versus a formal MAUD-based approach. For moderate-to-severe AUD, naltrexone or acamprosate plus outpatient therapy is the evidence-supported approach. Reframe is not a substitute. It may be a reasonable adjunct for patients in a formal MAUD-based plan who want additional in-pocket structure.

The pricing question

Reframe is a paid product, typically sold on a subscription basis with pricing that varies with promotional cycles. A few observations:

  • The subscription model means cost is proportional to engagement. Users who engage for the full program pay more than users who drop off.
  • Coaching and other add-ons are separate costs.
  • For patients with insurance, outpatient therapy and MAUD are usually covered, sometimes at lower out-of-pocket cost than a full Reframe subscription.
  • For patients without insurance, Reframe is substantially cheaper than private-pay therapy.

What to watch for

A few practical considerations:

  • Set a specific goal before starting. The app supports moderation and abstinence; pick one and revisit it periodically rather than drifting.
  • Pay attention to withdrawal symptoms. If stopping drinking triggers tremor, sweating, anxiety that escalates rather than resolves, or other physical symptoms, stop the app approach and see a clinician.
  • Notice if mood worsens. The daily content touches on emotional material. If depression or anxiety escalates during use, adjunctive clinical support is appropriate.
  • Combine with peer community if that fits. AA, SMART Recovery, or Moderation Management alongside Reframe can be complementary rather than redundant.
  • Do not use as a substitute for clinical care if severity warrants clinical care. This is the main failure mode.

The bottom line

Reframe is a reasonable consumer tool for motivated non-severe alcohol users who prefer a structured, self-directed, app-based approach. Its design is aligned with evidence-based approaches; its specific efficacy has not been established by the gold-standard research. For moderate-to-severe alcohol use disorder, for patients with physical dependence, and for patients with significant co-occurring conditions, it is not an adequate substitute for clinical care. Treated as an adjunct or as an entry point for mild-end patients, it can be useful. Treated as a substitute for MAUD-based clinical care in severity that warrants it, it is not.


What to read next

Key takeaways
If you are working through a hard moment, here is a reminder of what this site is for.

Most people with substance use disorders can be treated effectively without residential rehab. Outpatient care, medications, and harm reduction are real options backed by clinical evidence. You do not have to make a permanent decision today. The next step can be small.

Get the Free One-Page Reflection

The Trade-Offs: a one-page reflection on your relationship with a substance. The single most useful exercise from our workbook, used in clinical practice. Free, no spam.

No spam. Unsubscribe any time.